Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 6/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | HTR1A | P08908 | 2/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.52 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.52 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.52 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.52 |
| ▸ | HTR1D | P28221 | 1/20 | 0.52 |
| ▸ | HTR1B | P28222 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30913173 | 1.00 | CYP2C19 (0.52) | CYP2C19LMNACYP3A4CYP1A2TSHR | |
| SCHEMBL30913172 | 1.00 | CYP2C19 (0.52) | CYP2C19LMNACYP3A4CYP1A2TSHR | |
| SCHEMBL10814873 | 0.86 | CYP2C19 (0.61) | CYP2C19LMNACYP3A4CYP1A2TSHR | |
| SCHEMBL10604162 | 0.85 | CYP2C19 (0.40) | CYP2C19LMNACYP3A4CYP1A2TSHR | |
| SCHEMBL10000643 | 0.85 | CYP2C19 (0.52) | CYP2C19LMNACYP3A4CYP1A2TSHR | |
| SCHEMBL10605065 | 0.84 | CYP2C19 (0.49) | CYP2C19LMNACYP3A4CYP1A2TSHR | |
| SCHEMBL30913183 | 0.83 | CYP2C19 (0.51) | CYP2C19LMNACYP3A4CYP1A2TSHR | |
| SCHEMBL9331710 | 0.83 | CYP2C19 (0.58) | CYP2C19LMNACYP3A4CYP1A2TSHR | |
| SCHEMBL1720100 | 0.83 | CYP2C19 (0.51) | CYP2C19LMNACYP3A4CYP1A2TSHR | |
| SCHEMBL29824041 | 0.83 | CYP2C19 (0.51) | CYP2C19LMNACYP3A4CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986196-A | Clean preparation method of antioxidant 1790 | 巨野百林化学有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-106699678-A | Synthesis method of antioxidant 1790 | 兰州精细化工高新技术开发公司 | 2017-05-24 | — | — | CN | disclosed |
| US-7807757-B2 | stabilizing and at the same time phase compatibilizing plastics or plastic compositions by incorporating maleic anhydride or acrylic acid grafted copolymer or terpolymer (styrene/butadiene/styrene block copolymer grafted with maleic anhydride) obtained by reacting with a benzotriazole compound | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-10-05 | — | — | US | disclosed |
| US-20080051521-A1 | Functionalized polymers | PFAENDNER RUDOLF | 2008-02-28 | — | — | US | disclosed |
| US-7300978-B2 | Functionalised polymers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-11-27 | — | — | US | disclosed |
| US-20040167291-A1 | Functionalised polymers | PFAENDNER RUDOLF (DE) | 2004-08-26 | — | — | US | disclosed |
| US-20020123577-A1 | Functionalised polymers | PFAENDNER RUDOLF (DE) | 2002-09-05 | — | — | US | disclosed |
| US-6362278-B1 | STABILIZATION USING STERIC HINDERED AMINE COMPOUND | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-03-26 | — | — | US | disclosed |
| EP-0935619-B1 | FUNCTIONALISED POLYMERS | CIBA SC HOLDING AG (CH) | 2001-06-20 | — | — | EP | disclosed |
| EP-0935619-A1 | FUNCTIONALISED POLYMERS | Ciba SC Holding AG (CH) | 1999-08-18 | — | — | EP | disclosed |
| WO-1998018830-A1 | FUNCTIONALISED POLYMERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-05-07 | — | — | WO | disclosed |
| US-3998863-A | ANTIOXIDANTS | AMERICAN CYANAMID COMPANY (US) | 1976-12-21 | — | — | US | disclosed |